Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Carcinoma, Non-Small-Cell Lung"
format_facet:"Elektronische Aufsätze"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=format_facet%3A%22Elektronische+Aufs%C3%A4tze%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=format_facet%3A%22Elektronische+Aufs%C3%A4tze%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Carcinoma%2C+Non-Small-Cell+Lung%22&filter%5B%5D=format_facet%3A%22Elektronische+Aufs%C3%A4tze%22&lookfor=%22ClinicalTrials.gov%22&type=JournalTitle
PubPharm (5.163)
1
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) : Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Pembrolizumab for Metastatic NSCLC Patients Expressing PD-L1 Who Have Their Own PDX : Pembrolizumab for Metastatic Non-small Cell Lung Cancer (NSCLC) Patients Expressing PD-L1 Who Have Their Own Patient-derived Xenograft (PDX): Comparative Study of Clinical Response and In-vivo Antitumor Response Using Their Humanized CD34 PDX (Hu-CD34 PDX)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC : A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy : A Phase II, Randomised Study of Nivolumab as Consolidation Therapy in Patients With Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer : Randomized Phase III Trial of MEDI4736 (Durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-Small Cell Lung Cancer, ALCHEMIST Trial : Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO (ACCIO)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies : Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT8009 in Patients With Nectin-4 Expressing Advanced Malignancies
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer : A Phase 1 Open-Label Study of HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Toward High Fidelity Adaptive Radiotherapy in the Thorax : Toward High Fidelity Adaptive Radiotherapy in the Thorax
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC) : A Phase 3 Open-Label, Randomized, Controlled, Global Study of Telisotuzumab Vedotin (ABBV-399) Versus Docetaxel in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[517]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Carcinoma, Non-Small-Cell Lung
Filter aufheben
Medienart: E-Artikel
Medienart
5.163
Aufsätze
E-Artikel
5.163
E-Ressourcen
Zeitschriftentitel
5.163
ClinicalTrials.gov
Thema
5.163
610
Carcinoma, Non-Small-Cell Lung
4.380
Study Type: Interventional
3.618
Lung Neoplasms
1.838
Phase: Phase 2
1.693
Recruitment Status: Completed
1.263
Recruitment Status: Recruiting
817
Phase: Phase 1
724
Study Type: Observational
654
Phase: Phase 3
623
Recruitment Status: Terminated
609
Recruitment Status: Active, not recruiting
443
Carcinoma
412
Recruitment Status: Unknown status
379
Medical Condition: Non-small Cell Lung Cancer
318
Medical Condition: Non Small Cell Lung Cancer
317
Recruitment Status: Not yet recruiting
298
Phase: Phase 1, Phase 2
276
Medical Condition: Non-Small Cell Lung Cancer
256
Medical Condition: Carcinoma, Non-Small-Cell Lung
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.237
2020-
1.824
2010-2019
102
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
5.163
Englisch
Haven't found what you're looking for?
Wird geladen...